Foreseeing and planning for all of the possibilities and pitfalls involved in bringing a biotechnology innovation from inception to widespread therapeutic use takes strong managerial skills and a solid grounding in biopharmaceutical research and development procedures. Unfortunately there has been a dearth of resources for this aspect of the field.

The future is now—this groundbreaking textbook illustrates how biotechnology has radically changed the way we think about health care Biotechnology is delivering not only new products to diagnose, prevent, and treat human disease but entirely new approaches to a wide range of difficult biomedical challenges. Because of advances in biotechnology, hundreds of new therapeutic agents, diagnostic tests, and vaccines have been developed and are available in the marketplace. In this jargon-free, easy-to-read textbook, the authors demystify the discipline of medical biotechnology and present a roadmap that provides a fundamental understanding of the wide-ranging approaches pursued by scientists to diagnose, prevent, and treat medical conditions. Medical Biotechnology is written to educate premed and medical students, dental students, pharmacists, optometrists, nurses, nutritionists, genetic counselors, hospital administrators, and individuals who are stakeholders in the understanding and advancement of biotechnology and its impact on the practice of modern medicine. Hardcover, 700 pages, full-color illustrations throughout, glossary, index.

As the field of medical biotechnology grows with new products and discoveries, so does the need for a holistic view of biotechnology in medicine. Biotechnology in Medical Sciences fulfills that need by delivering a detailed overview of medical biotechnology as it relates to human diseases and epidemiology, bacteriology and antibiotics, virology and vaccines, immunology and monoclonal antibodies, recombinant DNA technology and therapeutic proteins, stem cell technology, tissue engineering, molecular diagnostics and forensic science, gene therapy, synthetic biology and nanomedicine, pharmacogenomics, bioethics, biobusiness and intellectual property rights, and career opportunities. Organized to follow the chronology of major medical biotechnology research, breakthroughs, and events, this first-of-its-kind text: Covers all aspects of medical biotechnology, from labs to clinics and basic to advanced applications Describes historical perspectives and modern discoveries in medical biotechnology Explains how various biotechnology products are used to treat and prevent disease Discusses the tools and techniques currently employed in medical biotechnology Includes a bibliography at the end of each chapter to encourage further study Complete with colorful illustrations and examples, Biotechnology in Medical Sciences provides a comprehensive yet accessible treatment of this growing field.

The Business of Healthcare Innovation is the first wide-ranging analysis of business trends in the manufacturing segment of the health care industry. In this leading edge volume, Professor Burns focuses on the key role of the 'producers' as the main source of innovation in health systems. Written by professors of the Wharton School and industry executives, this book provides a detailed overview of the pharmaceutical, biotechnology, genomics/proteomics, medical device and information technology sectors. It analyses the market structures of these sectors as well as the business models and corporate strategies of firms operating within them. Most importantly, the book describes the growing convergence between these sectors and the need for executives in one sector to increasingly draw upon trends in the others. It will be essential reading for students and researchers in the field of health management, and of great interest to strategy scholars, industry practitioners and management consultants.

Drawing on the work of the Roundtable on Evidence-Based Medicine, the 2007 IOM Annual Meeting assessed some of the rapidly occurring changes in health care related to new diagnostic and treatment tools, emerging genetic insights, the developments in information technology, and healthcare costs, and discussed the need for a stronger focus on evidence to ensure that the promise of scientific discovery and technological innovation is efficiently captured to provide the right care for the right patient at the right time. As new discoveries continue to expand the universe of medical interventions, treatments, and methods of care, the need for a more systematic approach to evidence development and application becomes increasingly critical. Without better information about the effectiveness of different treatment options, the resulting uncertainty can lead to the delivery of services that may be unnecessary, unproven, or even harmful. Improving the evidence-base for medicine holds great potential to increase the quality and efficiency of medical care. The Annual Meeting, held on October 8, 2007, brought together many of the nation's leading authorities on various aspects of the issues - both challenges and opportunities - to present their perspectives and engage in discussion with the IOM membership.

" The findings of this book are a valuable contribution to the state of our knowledge about modern biotechnology, to UNU-IAS efforts to raise awareness among policy makers and stakeholders and to educating the public at large about the greater implications and prospects concerning the advances of this rapidly growing new technology." -- From the Foreword by A. H. Zakri, Director of the United Nations University Institute of Advanced Studies

Medical Biotechnology is designed as a textbook for undergraduate students of biotechnology, especially those who are pursuing a course in Human Molecular Genetics. Medical Biotechnology as a separate course is offered in a few universities and is increasingly finding favour as a mainstreamdisciplineMedical Biotechnology is a multidisciplinary subject that brings together the combined research and applications from the fields of r-DNA technology, microbiology and medicine. The book starts with a brief overview of biotechnology and healthcare. It then goes on to describe various therapeuticaltechniques based on DNA, RNA and proteins. Key topics like molecular pharming, drug design and delivery, chiral technology, regenerative medicine, nanomedicine and pharmacogenomics are dealt with in great detail. Emphasis is laid on management and analysis of clinical data, various processesinvolving biomolecules and the use of softwares to analyze genomes and proteomes.The topics are presented in a lucid, methodical way and care has been taken to keep the level of discussion simple. The various concepts are complemented by numerous practical examples and end-chapter exercises.